Edition:
United States

Spark Therapeutics Inc (ONCE.OQ)

ONCE.OQ on NASDAQ Stock Exchange Global Select Market

81.39USD
20 Apr 2018
Change (% chg)

$0.23 (+0.28%)
Prev Close
$81.16
Open
$80.78
Day's High
$82.50
Day's Low
$80.65
Volume
150,978
Avg. Vol
303,933
52-wk High
$91.75
52-wk Low
$41.06

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 7.41 -1.745
Sep '17 1.90 -1.898
Jun '17 1.48 -2.401
Mar '17 1.27 -1.699
FY 2016 Dec '16 16.30 -1.205
Sep '16 1.30 -1.072
Jun '16 1.29 -1.044
Mar '16 1.29 -0.954
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 18 23.74 150.40 5.30 --
Quarter Ending Sep-18 18 44.92 90.90 11.90 --
Year Ending Dec-18 20 165.27 333.00 46.00 156.79
Year Ending Dec-19 19 149.27 243.19 42.10 369.04
Earnings (per share)
Quarter Ending Jun-18 19 -1.13 1.68 -2.13 --
Quarter Ending Sep-18 19 -0.59 1.95 -1.79 --
Year Ending Dec-18 20 -3.20 1.73 -7.31 -2.49
Year Ending Dec-19 19 -4.23 -1.00 -9.65 2.45
LT Growth Rate (%) 1 17.00 17.00 17.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 188.22 33.60
P/E High - Last 5 Yrs. -- 284.72 45.95
P/E Low - Last 5 Yrs. -- 95.76 24.93
Beta -- 0.75 0.80
Price to Sales (TTM) 251.05 136.15 7.07
Price to Book (MRQ) 5.88 19.54 5.13
Price to Tangible Book (MRQ) 5.91 24.07 6.73
Price to Cash Flow (TTM) -- 122.99 25.52
% Owned Institutions -- 11.18 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.51
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.94 3.93
Payout Ratio(TTM) -- 9.18 20.35

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -54.56 103.73 9.02
Sales (TTM) vs TTM 1 Yr. Ago -40.22 79.72 10.83
Sales - 5 Yr. Growth Rate -- 33.87 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -44.80 -66.87 22.25
EPS (TTM) vs TTM 1 Yr. Ago -81.09 -- --
EPS - 5 Yr. Growth Rate -- 47.46 10.26
Capital Spending - 5 Yr. Growth Rate -- 45.48 10.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.53
Current Ratio (MRQ) 9.93 5.97 3.62
LT Debt to Equity (MRQ) 0.18 23.32 11.31
Total Debt to Equity (MRQ) 0.24 25.75 13.97
Interest Coverage (TTM) -- -186.61 30.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 36.56 54.01
Gross Margin - 5 Yr. Avg. -- 55.38 52.12
EBITD Margin (TTM) -1,904.12 -- --
EBITD - 5 Yr. Avg -- -152.18 15.89
Operating Margin (TTM) -2,142.59 -563.03 4.33
Operating Margin - 5 Yr. Avg. -- -164.18 11.25
Pre-Tax Margin (TTM) -2,108.84 -535.84 4.97
Pre-Tax Margin - 5 Yr. Avg. -- -171.12 11.56
Net Profit Margin (TTM) -2,100.86 -524.81 1.58
Net Profit Margin - 5 Yr. Avg. -- -171.01 7.89
Effective Tax Rate (TTM) -- -0.44 31.30
Effective Tax Rate - 5 Yr. Avg. -- 18.14 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 38,304 23,887,722 816,988,634
Net Income/Employee (TTM) -804,705 956,935 96,050,323
Receivable Turnover (TTM) 0.98 6.24 5.56
Inventory Turnover (TTM) -- 2.37 3.45
Asset Turnover (TTM) 0.02 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -51.17 -0.77 10.54
Return on Assets - 5 Yr. Avg. -- 0.70 11.56
Return on Investment (TTM) -55.90 -0.74 13.19
Return on Investment - 5 Yr. Avg. -- 4.20 14.97
Return on Equity (TTM) -60.07 -2.80 15.00
Return on Equity - 5 Yr. Avg. -- -0.05 16.25
  1 Year 3 Year 5 Year
Sales % -40.22 166.99 --
EPS (TTM) % -77.63 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Spark Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 29.01 25.05 99 9
13 Week 58.78 67.11 99 72
26 Week -0.59 -4.12 99 89
52 Week 50.39 32.69 99 77
YTD 58.28 58.49 99 88
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 243
Total Shares Held: 38,636,478
3 Mo. Net Change: 341,273
# New Positions: 1
# Closed Positions: 4
# Increased Positions: 14
# Reduced Positions: 15
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.